Serum thyroglobulin determination in thyroid cancer patients

被引：31
作者：
Francis, Zelia [1 ]
Schlumberger, Martin [1 ]
机构：
[1] Univ Paris 09, Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2008年 / 22卷 / 06期
关键词：
thyroglobulin; thyroid cancer; follow-up; neck ultrasonography; recombinant human TSH;
D O I：
10.1016/j.beem.2008.09.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum thyroglobulin determination plays a central role, in combination with neck ultrasonography, in the follow-up of thyroid cancer patients. Its specificity is improved by thyroid remnant ablation, and its sensitivity is optimal following prolonged withdrawal or stimulation with recombinant human thyroid-stimulating hormone (TSH). Modern methods with an improved functional sensitivity may facilitate its use during follow-up.
引用
收藏
页码：1039 / 1046
页数：8
相关论文
共 43 条
[1]   Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment [J].
Bachelot, A ;
Leboulleux, S ;
Baudin, E ;
Hartl, DM ;
Caillou, B ;
Travagli, JP ;
Schlumberger, M .
CLINICAL ENDOCRINOLOGY, 2005, 62 (03) :376-379
[2]   Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma [J].
Bachelot, A ;
Cailleux, AF ;
Klain, M ;
Baudin, E ;
Ricard, M ;
Bellon, N ;
Caillou, B ;
Travagli, JP ;
Schlumberger, M .
THYROID, 2002, 12 (08) :707-711
[3]   Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients [J].
Baudin, E ;
Do Cao, C ;
Cailleux, AF ;
Leboulleux, S ;
Travagli, JP ;
Schlumberger, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1107-1111
[4]   Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal [J].
Borget, I. ;
Corone, C. ;
Nocaudie, M. ;
Allyn, M. ;
Iacobelli, S. ;
Schlumberger, M. ;
De Pouvourville, G. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) :531-538
[5]   Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? [J].
Cailleux, AF ;
Baudin, E ;
Travagli, JP ;
Ricard, M ;
Schlumberger, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :175-178
[6]   Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels [J].
Castagna, M. G. ;
Brilli, L. ;
Pilli, T. ;
Montanaro, A. ;
Cipri, C. ;
Fioravanti, C. ;
Sestini, F. ;
Capezzone, M. ;
Pacini, F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) :76-81
[7]   Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma [J].
Chin, BB ;
Patel, P ;
Cohade, C ;
Ewertz, M ;
Wahl, R ;
Ladenson, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :91-95
[8]   Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens [J].
Chiovato, L ;
Latrofa, F ;
Braverman, LE ;
Pacini, F ;
Capezzone, M ;
Masserini, L ;
Grasso, L ;
Pinchera, A .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) :346-351
[9]  
DEMERS LM, LAB SUPPORT DIAGNOSI
[10]   Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy [J].
Durante, C. ;
Haddy, N. ;
Baudin, E. ;
Leboulleux, S. ;
Hartl, D. ;
Travagli, J. P. ;
Caillou, B. ;
Ricard, M. ;
Lumbroso, J. D. ;
De Vathaire, F. ;
Schlumberger, M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :2892-2899
12345